Company intelligence / Profile preview

Nutriband

Peachtree Corners, Georgia, United Statesnutriband.com ↗
Ownership
Public · NTRB
Development stage
Preclinical
01

Overview

Nutriband’s lead product—a fentanyl patch with AVERSA™ abuse-deterrent technology—is in clinical development. The company has received a Notice of Allowance for a new U.S. patent covering this technology and aims to set new safety standards for opioid patches by preventing misuse and accidental exposure. Additional programs are at preclinical or early clinical stages focused on expanding the platform to other drugs with abuse potential or those benefiting from improved compliance via transdermal delivery[5].

Therapeutic areas
OtherPsychiatryNeurology
Modalities
Transdermal drug delivery systems; focus on transdermal patches for small molecules and biologics
Industry
Biotech
02

Drug pipeline

3 assets

AVERSA Buprenorphine

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Kindeva Drug Delivery—exclusive product development partnership involving shared costs and milestone paymentsCharlotte FC associate partnership agreement
04

Financials

Market cap
$74.2M
Total revenue
$437.5K
Enterprise value
$70.9M

Beyond the preview

Go deeper on Nutriband.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutriband.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call